Chemical or electrolytic lesion of the substantia nigra: early effects on neostriatal dopamine metabolism.
D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism*; D006892:Hydroxydopamines / Q000494:pharmacology; D006900:Hydroxylation; D008297:Male; D009434:Neural Pathways; D051381:Rats; D011919:Rats, Inbred Strains; D013378:Substantia Nigra / Q000187:drug effects / Q000502:physiology*; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism
D000613:Aminobutyrates; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006892:Hydroxydopamines; D014316:Tritium; D014443:Tyrosine; D004298:Dopamine